Bar Harbor Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-885
| Closed | -$248K | – | 247 |
|
|
2021
Q1 | $248K | Sell |
885
-136
| -13% | -$36.7K | 0.02% | 222 |
|
|
2020
Q4 | $250K | Hold |
1,021
| – | – | 0.03% | 211 |
|
|
2020
Q3 | $290K | Hold |
1,021
| – | – | 0.03% | 194 |
|
|
2020
Q2 | $273K | Sell |
1,021
-69
| -6% | -$20.7K | 0.03% | 195 |
|
|
2020
Q1 | $345K | Sell |
1,090
-178
| -14% | -$54K | 0.05% | 182 |
|
|
2019
Q4 | $376K | Sell |
1,268
-1,280
| -50% | -$355K | 0.04% | 218 |
|
|
2019
Q3 | $593K | Sell |
2,548
-235
| -8% | -$54.7K | 0.07% | 189 |
|
|
2019
Q2 | $651K | Sell |
2,783
-247
| -8% | -$57K | 0.08% | 181 |
|
|
2019
Q1 | $716K | Sell |
3,030
-702
| -19% | -$221K | 0.09% | 163 |
|
|
2018
Q4 | $1.12M | Buy |
3,732
+496
| +15% | +$158K | 0.15% | 122 |
|
|
2018
Q3 | $1.14M | Buy |
3,236
+110
| +4% | +$37.9K | 0.13% | 129 |
|
|
2018
Q2 | $907K | Buy |
3,126
+3
| +0.1% | +$843 | 0.11% | 143 |
|
|
2018
Q1 | $855K | Buy |
3,123
+4
| +0.1% | +$1.24K | 0.1% | 150 |
|
|
2017
Q4 | $994K | Buy |
3,119
+1,219
| +64% | +$391K | 0.12% | 137 |
|
|
2017
Q3 | $595K | Sell |
1,900
-12
| -0.6% | -$3.55K | 0.07% | 177 |
|
|
2017
Q2 | $519K | Sell |
1,912
-590
| -24% | -$156K | 0.06% | 194 |
|
|
2017
Q1 | $684K | Sell |
2,502
-241
| -9% | -$68.1K | 0.08% | 173 |
|
|
2016
Q4 | $778K | Sell |
2,743
-50
| -2% | -$14.8K | 0.09% | 173 |
|
|
2016
Q3 | $874K | Sell |
2,793
-10
| -0.4% | -$2.96K | 0.1% | 158 |
|
|
2016
Q2 | $678K | Buy |
2,803
+75
| +3% | +$19.8K | 0.08% | 176 |
|
|
2016
Q1 | $710K | Buy |
2,728
+50
| +2% | +$13.2K | 0.09% | 167 |
|
|
2015
Q4 | $820K | Buy |
2,678
+177
| +7% | +$50.9K | 0.1% | 152 |
|
|
2015
Q3 | $730K | Buy |
2,501
+630
| +34% | +$208K | 0.1% | 158 |
|
|
2015
Q2 | $755K | Sell |
1,871
-8
| -0.4% | -$3.21K | 0.09% | 156 |
|
|
2015
Q1 | $794K | Sell |
1,879
-447
| -19% | -$176K | 0.1% | 147 |
|
|
2014
Q4 | $790K | Buy |
2,326
+50
| +2% | +$16.2K | 0.1% | 146 |
|
|
2014
Q3 | $753K | Hold |
2,276
| – | – | 0.1% | 146 |
|
|
2014
Q2 | $717K | Buy |
2,276
+85
| +4% | +$25.6K | 0.09% | 153 |
|
|
2014
Q1 | $671K | Sell |
2,191
-850
| -28% | -$270K | 0.09% | 159 |
|
|
2013
Q4 | $850K | Hold |
3,041
| – | – | 0.11% | 134 |
|
|
2013
Q3 | $732K | Sell |
3,041
-100
| -3% | -$22.4K | 0.1% | 145 |
|
|
2013
Q2 | $676K | Buy |
+3,141
| New | +$671K | 0.1% | 150 |
|
Other funds holding BIIB
Bar Harbor Wealth Management's BIIB Position: Q2 2021 in Review
Bar Harbor Wealth Management sold out of Biogen (BIIB) in Q2 2021, closing a stake of 885 shares — an estimated $248K sold.
Bar Harbor Wealth Management first reported a position in BIIB in Q2 2013 and held it in 32 quarters. The position peaked at $1.14M in Q3 2018. 1,105 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.
- Bar Harbor Wealth Management reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
- Bar Harbor Wealth Management sold 885 Biogen shares in Q2 2021, an estimated $248K.
- Bar Harbor Wealth Management first reported a position in Biogen in Q2 2013 and held it in 32 quarters.
- Bar Harbor Wealth Management's Biogen position peaked at $1.14M in Q3 2018.
- 1,105 funds tracked by Wall St. Rank held Biogen as of Q2 2021.
Based on Bar Harbor Wealth Management's 13F filing for Q2 2021, filed 11 Aug 2021.